SHAREHOLDERS’ EQUITY | NOTE 9 – SHAREHOLDERS’ EQUITY The Company’s authorized capital stock consists of 100,000,000 0.01 10,000,000 0.001 All shares of common stock have equal voting rights and, when validly issued and outstanding, are entitled to one non-cumulative vote per share in all matters to be voted upon by shareholders. Shares of common stock have no pre-emptive, subscription, conversion or redemption rights and may be issued only as fully paid and non-assessable shares. Holders of common stock are entitled to equal ratable rights to dividends and distributions with respect to the common stock, as may be declared by the Company’s Board of Directors (the “Board”) out of funds legally available. In the event of a liquidation, dissolution or winding up of the affairs of the Company, the holders of common stock are entitled to share ratably in all assets remaining available for distribution to them after payment or provision for all liabilities and any preferential liquidation rights of any preferred stock then outstanding. Following is an analysis of common stock issuances during the years ended August 31, 2022 and 2021: August 31, 2022 In October 2021, the Company issued 41,231 During the year ended August 31, 2022, the Company issued 90,594 136,505 41,502 26,833 In January 2020, the Company entered into three separate consulting agreements for total consideration of 699,999 233,333 448,000 0.64 24 699,999 87,501 74,667 224,000 During the year ended August 31, 2022, the holders of 720,000 6,000 239,700 0.30 0.45 0.20 During the year ended August 31, 2022, a total of 100,000 77,330 0.45 August 31, 2021 In October 2020, the Company issued 61,936 92,500 During the year ended August 31, 2021, the Company issued 83,345 142,500 47,500 41,233 During the year ended August 31, 2021, the holders of 76,000 220,000 81,300 0.10 0.35 0.20 0.45 During the year ended August 31, 2021, a total of 200,000 169,506 0.22 0.45 Options The following table sets forth certain information as of August 31, 2022 and 2021 concerning common stock that may be issued upon the exercise of options not covered by the Amended 2008 Plan and pursuant to purchases of stock under the Amended 2008 Plan (All options are fully vested and exercisable at August 31, 2022 and 2021): Schedule of options Shares Weighted Price Weighted (In Years) Aggregate Value Outstanding, vested and exercisable at August 31, 2021 1,763,500 $ 0.35 3.45 $ 2,028,025 Options granted 174,000 0.60 — — Options exercised (420,000 ) 0.28 — — Options cancelled/forfeited/expired (40,000 ) 0.30 — — Outstanding, vested and exercisable at August 31, 2021 1,477,500 0.40 2.68 $ 1,523,430 Options granted 120,000 0.30 — — Options exercised (820,000 ) 0.35 — — Options cancelled/forfeited/expired (257,500 ) 0.45 — — Outstanding, vested and exercisable at August 31, 2022 520,000 $ 0.31 2.79 $ 693,300 Amended 2008 Stock Option Plan In September 2008, the Board adopted the 2008 Stock Option Plan (the “2008 Plan”), which was approved by the Company’s shareholders and provided 2,000,000 7,000,000 9,000,000 5,625,000 During the year ended August 31, 2022, the Company granted a total of 120,000 250,768 0.25 2.33 197 202 0.00 5 250,768 During the year ended August 31, 2021, the Company granted a total of 174,000 353,497 0.27 205.58 0.00 5 353,497 Warrants Warrant activity for the years ended August 31, 2021 and 2020 was as follows: Schedule of warrants Shares Weighted Price Weighted (In Years) Aggregate Value Outstanding and exercisable at August 31, 2020 3,318,038 $ 0.40 0.28 $ 3,649,842 Warrants granted 10,000 0.01 Warrants exercised (76,000 ) 0.33 Warrants cancelled/forfeited/expired (3,218,038 ) 0.10 — — Outstanding and exercisable at August 31, 2021 34,000 $ 0.10 1.2 $ 45,660 Warrants granted — — — — Warrants exercised (6,000 ) 0.20 — — Warrants cancelled/forfeited/expired (16,000 ) 0.10 — — Outstanding and exercisable at August 31, 2022 12,000 $ 0.04 1.0 $ 23,780 During the year ended August 31, 2021, the Company granted a total of 10,000 20,442 0.27 205.58 0.00 3 20,442 |